Avalyn Pharma Inc.
Organization details
- Legal name
- Avalyn Pharma Inc.
- Former names
- Genoa Pharmaceuticals, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Boston
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- AVLN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001540171
- EIN
- 45-2463191
Board of directors
-
David Matthew Friedman · DirectorSince 2026
-
Erin Lavelle · DirectorSince 2026
-
Heather D. Turner · DirectorSince 2026
-
Jill Carroll · DirectorSince 2026
-
Jon Congleton · DirectorSince 2026
-
Kate Haviland · DirectorSince 2026
-
Lyn Baranowski · Director · Chief Executive OfficerSince 2026
-
Robert J. Meyer · DirectorSince 2026
Chief executives
Board connections
5 of this board's directors also sit on 9 other boards. 9 are in the same sector.
-
Benitec Biopharma Inc. Same sectorvia David Matthew Friedman
-
Bicara Therapeutics Inc. Same sectorvia Kate Haviland
-
Fulcrum Therapeutics Inc. Same sectorvia Kate Haviland
-
Immunic Inc. Same sectorvia Jon Congleton
-
Jade Biosciences Inc. Same sectorvia Erin Lavelle
-
LB Pharmaceuticals Inc Same sectorvia Heather D. Turner
-
Mineralys Therapeutics Inc. Same sectorvia Jon Congleton
-
Neurogene Inc. Same sectorvia Erin Lavelle
-
Veradermics Incorporated Same sectorvia David Matthew Friedman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $24,999,984
- 4 purchases by 3 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 1, 2026 | Novo Holdings A/S 10% owner | Derivative conversion | +3,327,734 | — | — |
| May 1, 2026 | FMR LLC 10% owner, See Remark 1 | Derivative conversion | +727,585 | — | — |
| May 1, 2026 | Jill Carroll Director | Derivative conversion | +1,419,298 | — | — |
| May 1, 2026 | Simeon George 10% owner | Derivative conversion | +1,419,298 | — | — |
| May 1, 2026 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% owner | Derivative conversion | +1,275,486 | — | — |
| May 1, 2026 | Novo Holdings A/S 10% owner | Open-market purchase | +555,555 | $18.00 | $9,999,990 |
| May 1, 2026 | FMR LLC 10% owner, See Remark 1 | Derivative conversion | +80,291 | — | — |
| May 1, 2026 | Jill Carroll Director | Derivative conversion | +489,486 | — | — |
| May 1, 2026 | Simeon George 10% owner | Derivative conversion | +489,486 | — | — |
| May 1, 2026 | FMR LLC 10% owner, See Remark 1 | Derivative conversion | +872,868 | — | — |
| May 1, 2026 | Jill Carroll Director | Open-market purchase | +277,778 | $18.00 | $5,000,004 |
| May 1, 2026 | Simeon George 10% owner | Open-market purchase | +277,778 | $18.00 | $5,000,004 |
| May 1, 2026 | FMR LLC 10% owner, See Remark 1 | Derivative conversion | +225,843 | — | — |
| May 1, 2026 | Simeon George 10% owner | Derivative conversion | +354,824 | — | — |
| May 1, 2026 | FMR LLC 10% owner, See Remark 1 | Derivative conversion | +377,948 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Avalyn Pharma Inc.
Who is the CEO of Avalyn Pharma Inc.?
Lyn Baranowski has been Avalyn Pharma Inc.'s Chief Executive Officer since April 2026.
How many directors are on Avalyn Pharma Inc.'s board?
Avalyn Pharma Inc.'s board has 8 directors: David Matthew Friedman, Erin Lavelle, Heather D. Turner, Jill Carroll, Jon Congleton, Kate Haviland, Lyn Baranowski and Robert J. Meyer.
Are Avalyn Pharma Inc. insiders buying or selling shares?
Over the last 12 months, Avalyn Pharma Inc. insiders bought $25.0 million of shares in 4 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="avalyn-pharma-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.